Aptevo Therapeutics Inc.

APVO · Nasdaq · SIC 2834: Pharmaceutical Preparations
247
SEC Filings

Business Summary

1 Item 1A. Risk Factors 25 Item 1B. Unresolved Staff Comments 62 Item 1C. Cybersecurity 62 Item 2. Properties 63 Item 3. Legal Proceedings 63 Item 4. Mine Safety Disclosures 63 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 64 Item 6. Not applicable 64 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 65 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 72 Ite...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAPVOdiscussed_in_filing Cybersecurity
topic_mentionAPVOdiscussed_in_filing Cybersecurity
topic_mentionAPVOdiscussed_in_filing Cybersecurity
topic_mentionAPVOdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126278EDGAR83K words
2025-02-142024-12-310000950170-25-020467EDGAR—
2024-03-052023-12-310000950170-24-025428EDGAR—
2023-03-302022-12-310000950170-23-010757EDGAR—
2022-03-242021-12-310001564590-22-011575EDGAR—
2021-03-312020-12-310001564590-21-016875EDGAR—
2020-03-252019-12-310001564590-20-012791EDGAR—
2019-03-182018-12-310001564590-19-008184EDGAR—
2018-03-132017-12-310001564590-18-005384EDGAR—
2017-03-312016-12-310001564590-17-005738EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269598EDGAR44K words
2025-08-112025-06-300000950170-25-106247EDGAR—
2025-05-152025-03-310000950170-25-072622EDGAR—
2024-11-072024-09-300000950170-24-122837EDGAR—
2024-08-082024-06-300000950170-24-093366EDGAR—
2024-05-082024-03-310000950170-24-055096EDGAR—
2023-11-142023-09-300000950170-23-063379EDGAR—
2023-08-102023-06-300000950170-23-040983EDGAR—
2023-05-112023-03-310000950170-23-020870EDGAR—
2022-11-102022-09-300001564590-22-037287EDGAR—
2022-08-112022-06-300001564590-22-029025EDGAR—
2022-05-122022-03-310001564590-22-019685EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126190EDGAR3K words
2026-03-110001193125-26-100539EDGAR—
2026-02-190001193125-26-057707EDGAR—
2026-02-030001193125-26-034473EDGAR—
2026-01-090001193125-26-008318EDGAR—
2025-12-290001193125-25-335497EDGAR—
2025-12-090001193125-25-312972EDGAR—
2025-11-060001193125-25-269470EDGAR—
2025-10-300001193125-25-258665EDGAR—
2025-09-160001193125-25-205107EDGAR—

247 total filings indexed. 215 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001671584
TickerAPVO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8987498d094d5d4457e816896db2215f793a2f450b301813d2508db2ae8691dc
parent: e4ac9abbd5b334ac034713a2a33645169d5eaa18808200c304dd499f94994a5b
content hash: 46a700f80789d89b04f2ae746dc3f4bc841d4f0b3678026d8d00cc6b6d81b993
signed: 2026-04-13T04:43:42.036Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf